Cargando…

Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus

An 80-year-old systemically stable female presented with sudden blurring of vision post the first dose of Covishield™, a non-replicating viral vector vaccine. On examination, she was found to have bilateral serous choroidal effusions. A thorough systemic and ocular workup was performed to rule out o...

Descripción completa

Detalles Bibliográficos
Autores principales: Arthi, M, Dabir, Supriya, Khatri, Manoj, Rajan, Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940547/
https://www.ncbi.nlm.nih.gov/pubmed/36453364
http://dx.doi.org/10.4103/ijo.IJO_946_22
_version_ 1784891103333318656
author Arthi, M
Dabir, Supriya
Khatri, Manoj
Rajan, Mohan
author_facet Arthi, M
Dabir, Supriya
Khatri, Manoj
Rajan, Mohan
author_sort Arthi, M
collection PubMed
description An 80-year-old systemically stable female presented with sudden blurring of vision post the first dose of Covishield™, a non-replicating viral vector vaccine. On examination, she was found to have bilateral serous choroidal effusions. A thorough systemic and ocular workup was performed to rule out other causes of choroidal effusion. The effusions resolved with tapering doses of oral and systemic steroids. To the best of our knowledge, at the time of submission, this is the first case of choroidal effusion being reported after the coronavirus disease 2019 (COVID-19) vaccine.
format Online
Article
Text
id pubmed-9940547
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-99405472023-02-21 Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus Arthi, M Dabir, Supriya Khatri, Manoj Rajan, Mohan Indian J Ophthalmol Case Report An 80-year-old systemically stable female presented with sudden blurring of vision post the first dose of Covishield™, a non-replicating viral vector vaccine. On examination, she was found to have bilateral serous choroidal effusions. A thorough systemic and ocular workup was performed to rule out other causes of choroidal effusion. The effusions resolved with tapering doses of oral and systemic steroids. To the best of our knowledge, at the time of submission, this is the first case of choroidal effusion being reported after the coronavirus disease 2019 (COVID-19) vaccine. Wolters Kluwer - Medknow 2022-12 2022-11-30 /pmc/articles/PMC9940547/ /pubmed/36453364 http://dx.doi.org/10.4103/ijo.IJO_946_22 Text en Copyright: © 2022 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Arthi, M
Dabir, Supriya
Khatri, Manoj
Rajan, Mohan
Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
title Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
title_full Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
title_fullStr Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
title_full_unstemmed Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
title_short Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
title_sort bilateral choroidal effusion following vaccination against sars-cov-2 virus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940547/
https://www.ncbi.nlm.nih.gov/pubmed/36453364
http://dx.doi.org/10.4103/ijo.IJO_946_22
work_keys_str_mv AT arthim bilateralchoroidaleffusionfollowingvaccinationagainstsarscov2virus
AT dabirsupriya bilateralchoroidaleffusionfollowingvaccinationagainstsarscov2virus
AT khatrimanoj bilateralchoroidaleffusionfollowingvaccinationagainstsarscov2virus
AT rajanmohan bilateralchoroidaleffusionfollowingvaccinationagainstsarscov2virus